Intravenous Vitamin C or “IVC” Therapy Is An Effective Therapy for Viral Infections And Needs To Be Taken More Seriously
At Regenerate Health Medical Center, we believe that the body has an innate ability to heal and protect itself, provided it has the right resources. Because we are all faced with a pandemic, it’s important to remember the basics (wash your hands, stay home if you’re sick or feel that you might be getting sick, etc…). But what if you want to be proactive in boosting your immune system or start to feel not 100%? What can you do to boost your immune system and give your body the resources it needs? IV Therapy is THE most effective way to get the anti-viral nutrients your body needs to fight off infection. A vaccine is months and months away, so why wait for something that isn’t guaranteed to work even when it is made available, when you could be taking measures now to protect yourself, your family and those around you?
Intravenous Vitamin C Therapy or “IVC” has been in use in medicine for decades and has been shown to be an effective treatment both as a preventative measure to keep the immune system robust, but also for those suffering from viral illnesses. Even hospitals in NYC are using it for their patients.
“Seriously sick coronavirus patients in New York state’s largest hospital system are being given massive doses of vitamin C — based on promising reports that it’s helped people in hard-hit China.”
“The patients who received vitamin C did significantly better than those who did not get vitamin C.“
“It helps a tremendous amount, but it is not highlighted because it’s not a sexy drug.“
Check out this Article From The New York Post.
Here at RHMC, IVC therapy is available to you and all those in our community. Our aim is to support our community in effectively preventing the worsening of the pandemic, and we ask that you share this powerful information so we all can be safer as a result.
HOW CAN I GET IVC THERAPY?
Available here at RHMC for the whole community, even walk-in patients
(Though if you are symptomatic please stay home)
Basic
Fastbag Immune IV
Walk in patients & Existing patients
Boost
Immune Support IV
Walk in patients with current labs & Existing patients
ULTIMATE
High Dose Vitamin IVC
Walk in Patients (required to establish care with RHMC) Existing Patients (extra labs maybe required)
CURRENT STUDIES
“Early Large Dose Intravenous Vitamin C is the Treatment of Choice for 2019-nCov Pneumonia”
IVC STUDIES
The below summary of an IVC study gives compelling evidence for the efficacy of IVC, calls for further studies and is a call to action to share this information so more people can benefit from this safe and effective therapy. For the specific information click the button below for the Full Report:
The above information is not intended to diagnose or treat and disease and is not a substitute for appropriate medical care.
“2019-nCov pneumonia is a rapidly developing disease with high morbidity and mortality rate. The key pathogenesis is the acute lung injury causing ARDS and death. Coronaviruses, influenza viruses and many other pandemic viral infections are usually associated with an increase oxidative stress leading to oxidative cellular damage resulting in multi-organ failure. Antioxidants administration therefore has a central role in the management of these conditions, in addition to the standard conventional supportive therapies. Preliminary clinical studies and case reports show that early administration of high dose IVC can improve clinical conditions of patients in ICU, ARDS and flu. It needs to be pointed that pandemics like 2019-nCov will happen in the future. Specific vaccines and antiviral drugs R&D take long time to develop and are not available for the current nCov epidemic and won’t be ready when the next pandemic strikes. IVC and other antioxidants are universal agents for ARDS that can be rapidly applied clinically. Given that high dose IVC is safe, can be effective, we call on the involved leadership and healthcare professionals to look into high dose IVC without further delay. More clinical studies of the IVC and oral VC (such as liposomal-encapsulated VC) are needed to develop standard protocols for the current use and future uses are urgently needed. We hope when the next pandemic strikes, we won’t be so helpless and we’ll be ready.”
